Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHR1 | P34998 | 12/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11023677 | 0.98 | CRHR1 (0.43) | CRHR1ESR1ALDH1A1TP53CYP3A4 | |
| Lithium Ion SCHEMBL19732781 | 0.98 | CRHR1 (0.43) | CRHR1ESR1ALDH1A1TP53CYP3A4 | |
| SCHEMBL21065755 | 0.98 | CRHR1 (0.43) | CRHR1ESR1ALDH1A1TP53CYP3A4 | |
| SCHEMBL25276708 | 0.92 | ALDH1A1 (0.45) | CRHR1ESR1ALDH1A1TP53CYP3A4 | |
| SCHEMBL19002230 | 0.91 | CYP3A4 (0.41) | CRHR1ESR1ALDH1A1TP53CYP3A4 | |
| SCHEMBL25228545 | 0.90 | ALDH1A1 (0.51) | CRHR1ESR1ALDH1A1TP53 | |
| SCHEMBL18769095 | 0.90 | CRHR1 (0.40) | CRHR1ESR1ALDH1A1TP53CYP3A4 | |
| SCHEMBL25277478 | 0.89 | ALDH1A1 (0.54) | CRHR1ESR1ALDH1A1TP53 | |
| SCHEMBL25277465 | 0.89 | ALDH1A1 (0.54) | CRHR1ESR1ALDH1A1TP53 | |
| SCHEMBL25225999 | 0.89 | ALDH1A1 (0.54) | CRHR1ESR1ALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 188 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4192820-A | Preparation of 3-methyl-2-buten-1-al | BASF AKTIENGESELLSCHAFT (DE) | 1980-03-11 | — | — | US | claimed |
| EP-3542775-B1 | COMPOSITION WITH EXCELLENT STORAGE STABILITY USING HIGHLY BASIC FILLER | SHOFU INC (JP) | 2025-04-02 | — | — | EP | disclosed |
| EP-4446310-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | Asahi Kasei Kabushiki Kaisha (JP) | 2024-10-16 | — | — | EP | disclosed |
| CN-112545900-B | Dental curable composition containing transition metal adsorbent | 株式会社松风 | 2024-02-13 | — | — | CN | disclosed |
| US-11767411-B2 | Curable composition containing transition metal adsorbent | SHOFU INC. (JP) | 2023-09-26 | — | — | US | disclosed |
| WO-2023106377-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | 旭化成株式会社 | 2023-06-15 | — | — | WO | disclosed |
| EP-4169919-A1 | PYRAZOLO[3,4-D]PYRIMIDINE-3-KETONE DERIVATIVE AS WEE-1 INHIBITOR | Wigen Biomedicine Technology (Shanghai) Co., Ltd. (CN) | 2023-04-26 | — | — | EP | disclosed |
| WO-2022260494-A1 | NOVEL COMPOUND HAVING INHIBITORY ACTIVITY AGAINST PENDRIN, AND PHARMACEUTICAL USES THEREOF | 연세대학교 산학협력단 | 2022-12-15 | — | — | WO | disclosed |
| US-20210189098-A1 | CURABLE COMPOSITION CONTAINING TRANSITION METAL ADSORBENT | SHOFU INC. (JP) | 2021-06-24 | — | — | US | disclosed |
| US-11033464-B2 | Composition with excellent storage stability using highly basic filler | SHOFU INC. (JP) | 2021-06-15 | — | — | US | disclosed |
| US-4200582-A | Preparation of α-hydroxy-β,β-dimethyl-γ-butyrolactone | BASF AKTIENGESELLSCHAFT (DE) | 1980-04-29 | — | — | US | disclosed |
| US-4192820-A | Preparation of 3-methyl-2-buten-1-al | BASF AKTIENGESELLSCHAFT (DE) | 1980-03-11 | — | — | US | disclosed |
| EP-0008013-A1 | Process for the preparation of carbonyl compounds | BASF Aktiengesellschaft (DE) | 1980-02-20 | — | — | EP | disclosed |
| EP-0007439-A1 | Sulphamic acid halides and method for their preparation | BASF Aktiengesellschaft (DE) | 1980-02-06 | — | — | EP | disclosed |
| EP-0006463-A1 | Process for the production of 2-substituted 1-alkyl-nitroimidazoles | BASF Aktiengesellschaft (DE) | 1980-01-09 | — | — | EP | disclosed |
| US-4165342-A | BY OXIDATIVE DEHYDROGENATION OF THE ALCOHOL, LAYERS OF SILVER AND COPPER CATALYST CRYSTALS | BASF AKTIENGESELLSCHAFT (DE) | 1979-08-21 | — | — | US | disclosed |
| EP-0002807-A1 | Process for the preparation of alpha-hydroxy-beta,beta-dimethyl-gamma-butyrolactone | BASF Aktiengesellschaft (DE) | 1979-07-11 | — | — | EP | disclosed |
| US-4153607-A | Process for the production of 4,5-disubstituted thiazoles | BASF AKTIENGESELLSCHAFT (DE) | 1979-05-08 | — | — | US | disclosed |
| US-4131620-A | ETHERIFICATION OF N-(2-HALOALKYL)-SULFAMIC ACID HALIDES | BASF AKTIENGESELLSCHAFT (DE) | 1978-12-26 | — | — | US | disclosed |
| US-3933423-A | Azoic dyeing of leather | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-01-20 | — | — | US | disclosed |